About Aptose Biosciences, Inc.

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
12770 High Bluff Drive, Suite 120, San Diego, California 92130, US
Description
Information
Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies. CG-806, our oral mutation-agnostic FLT3/BTK inhibitor, is being developed for the treatment of patients with certain B-cell malignancies, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and certain non-Hodgkin’s lymphomas (NHL) who are resistant or intolerant to conventional treatments. CG-806 is also being developed for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML), including the emerging populations resistant to approved targeted therapies. APTO-253, our first-in-class MYC Inhibitor, is being developed for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

Aptose Biosciences, Inc. Alternatives

Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Aptose Biosciences, Inc.

What is Aptose Biosciences, Inc. email format?

The widely used Aptose Biosciences, Inc. email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.


What is Aptose Biosciences, Inc. customer service number?

To contact Aptose Biosciences, Inc. customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more